JP7055638B2 - 幹細胞からの筋肉系列細胞の生成 - Google Patents

幹細胞からの筋肉系列細胞の生成 Download PDF

Info

Publication number
JP7055638B2
JP7055638B2 JP2017555573A JP2017555573A JP7055638B2 JP 7055638 B2 JP7055638 B2 JP 7055638B2 JP 2017555573 A JP2017555573 A JP 2017555573A JP 2017555573 A JP2017555573 A JP 2017555573A JP 7055638 B2 JP7055638 B2 JP 7055638B2
Authority
JP
Japan
Prior art keywords
cells
satellite
days
longer
pluripotent stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2017555573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018518943A (ja
JP2018518943A5 (OSRAM
Inventor
ウリ シュミット，
レスリー キャロン，
Original Assignee
ソニック マスター リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ソニック マスター リミテッド filed Critical ソニック マスター リミテッド
Publication of JP2018518943A publication Critical patent/JP2018518943A/ja
Publication of JP2018518943A5 publication Critical patent/JP2018518943A5/ja
Application granted granted Critical
Publication of JP7055638B2 publication Critical patent/JP7055638B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • C12N5/0659—Satellite cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
JP2017555573A 2015-04-22 2016-04-22 幹細胞からの筋肉系列細胞の生成 Expired - Fee Related JP7055638B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562151352P 2015-04-22 2015-04-22
US62/151,352 2015-04-22
PCT/AU2016/000144 WO2016168890A1 (en) 2015-04-22 2016-04-22 Generation of muscle-lineage cells from stem cells

Publications (3)

Publication Number Publication Date
JP2018518943A JP2018518943A (ja) 2018-07-19
JP2018518943A5 JP2018518943A5 (OSRAM) 2019-06-06
JP7055638B2 true JP7055638B2 (ja) 2022-04-18

Family

ID=60254709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017555573A Expired - Fee Related JP7055638B2 (ja) 2015-04-22 2016-04-22 幹細胞からの筋肉系列細胞の生成

Country Status (7)

Country Link
US (1) US20180346879A1 (OSRAM)
EP (1) EP3286301B1 (OSRAM)
JP (1) JP7055638B2 (OSRAM)
CN (1) CN107709545A (OSRAM)
AU (1) AU2016250905B2 (OSRAM)
CA (1) CA2983332A1 (OSRAM)
WO (1) WO2016168890A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL301900A (en) 2014-11-21 2023-06-01 Regeneron Pharma Methods and compositions for targeted genetic modification using paired guide rnas
WO2017100498A1 (en) 2015-12-11 2017-06-15 The Johns Hopkins University Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy
JP7090544B2 (ja) * 2016-04-27 2022-06-24 武田薬品工業株式会社 骨格筋前駆細胞及び骨格筋細胞の製造方法
JP7324583B2 (ja) 2016-05-20 2023-08-10 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 複数のガイドｒｎａを使用して免疫寛容を破綻させるための方法
AU2017351638A1 (en) 2016-10-26 2019-06-13 Genea Biocells USA (Holdings), Inc. Improved generation of muscle lineage cells and therapeutic uses thereof
US12365875B2 (en) 2017-01-06 2025-07-22 The Regents Of The University Of California Methods for generating skeletal muscle progenitor cells
CN107937338B (zh) * 2017-11-30 2021-08-03 中山大学 一种来自多能干细胞的中胚层谱系间充质干细胞及其制备方法
CN110859854A (zh) * 2018-08-08 2020-03-06 上海市东方医院 治疗神经源性肌肉萎缩的药物组合物及其制法和应用
JP7033095B2 (ja) * 2019-03-04 2022-03-09 日清食品ホールディングス株式会社 三次元筋組織とその製造方法
US20220411825A1 (en) * 2019-11-20 2022-12-29 Vita Therapeutics, Inc. Method of engineering hypoimmunogenic muscle precursor cells
JP7540893B2 (ja) * 2020-02-27 2024-08-27 テルモ株式会社 Ｃｄ５６陽性細胞の比率を高めるための組成物
CN111826451A (zh) * 2020-09-11 2020-10-27 中国肉类食品综合研究中心 实时荧光定量pcr检测猪肌肉调节因子的引物组及其应用
WO2022093665A1 (en) * 2020-10-26 2022-05-05 University Of Massachusetts Methods and compositions for treatment of muscle disease with ipsc-induced human skeletal muscle stem cells
WO2022140300A1 (en) * 2020-12-22 2022-06-30 Ixcells Biotechnolgies Usa, Inc. Methods and compositions for differentiating skeletal muscle
US20240360415A1 (en) * 2021-08-09 2024-10-31 Aleph Farms Ltd. Muscle cells differentiated from pluripotent cells, methods of producing same and use thereof
KR20240152443A (ko) * 2023-04-12 2024-10-22 이엔셀 주식회사 근력 약화 관련 질환 치료제 스크리닝 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013138623A1 (en) 2012-03-14 2013-09-19 Children's Medical Center Corporation High-throughput image-based chemical screening in zebrafish blastomere cell culture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143842A (en) 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
WO2007126077A1 (ja) * 2006-04-28 2007-11-08 Asubio Pharma Co., Ltd. 多能性幹細胞から心筋細胞を分化誘導する方法
AU2010355614B2 (en) * 2010-06-13 2015-07-02 Institute Of Biophysics, Chinese Academy Of Sciences Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
WO2014015777A1 (zh) * 2012-07-23 2014-01-30 中国科学院生物物理研究所 体外诱导多能干细胞分化为心室肌细胞的方法
AU2014268197A1 (en) * 2014-02-11 2015-08-27 Monash University Muscle cell production
CN104293730B (zh) * 2014-09-23 2017-07-28 云南中科灵长类生物医学重点实验室 多能干细胞体外定向分化为心肌细胞的方法
WO2016108288A1 (ja) * 2014-12-29 2016-07-07 国立大学法人京都大学 骨格筋前駆細胞の製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013138623A1 (en) 2012-03-14 2013-09-19 Children's Medical Center Corporation High-throughput image-based chemical screening in zebrafish blastomere cell culture

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Journal of Bone and Mineral Research, 2010, Vol.25, No.6, pp.1216-1233
Methods, 2016, Vol.101, pp.73-84
Nature Biotechnology, 2015, Vol.33, No.9, pp.962-969, ONLINE METHODS
Stem Cell Reports, 2013, Vol.1, pp.620-631
Stem Cell Reports, 2014, Vol.2, pp.92-106
Stem Cell Reports, 2014, Vol.3, pp.516-529
Stem Cells, 2016, Vol.34, pp.299-310

Also Published As

Publication number Publication date
EP3286301B1 (en) 2021-07-28
AU2016250905B2 (en) 2022-02-10
WO2016168890A1 (en) 2016-10-27
JP2018518943A (ja) 2018-07-19
AU2016250905A8 (en) 2018-03-15
EP3286301A1 (en) 2018-02-28
AU2016250905A1 (en) 2017-11-09
EP3286301A4 (en) 2019-02-20
US20180346879A1 (en) 2018-12-06
CA2983332A1 (en) 2016-10-27
WO2016168890A8 (en) 2017-11-30
CN107709545A (zh) 2018-02-16

Similar Documents

Publication Publication Date Title
JP7055638B2 (ja) 幹細胞からの筋肉系列細胞の生成
Wiley et al. cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness
Xiao et al. Neurotrophic factor GDNF promotes survival of salivary stem cells
JP6792844B6 (ja) 網膜色素上皮細胞の製造方法
US20150250824A1 (en) Methods and compositions for expansion of stem cells and other cells
US20020136709A1 (en) In vitro-derived adult pluripotent stem cells and uses therefor
US20240002811A1 (en) Methods for Generation for Pluripotent and Multipotent Cells
JP6473686B2 (ja) 細胞の選別方法
Songstad et al. Generating iPSC-derived choroidal endothelial cells to study age-related macular degeneration
CN108779435B (zh) 用于重新衍生不同的多能干细胞衍生的褐色脂肪细胞的方法
US20100190250A1 (en) Methods of Rejuvenating Cells In Vitro and In Vivo
KR20140004724A (ko) 전분화능을 위한 선천적 잠재력을 갖는 체세포
CN112839709A (zh) 治疗神经退行性疾病的神经干细胞组合物和方法
Novosadova et al. A platform for studying molecular and cellular mechanisms of Parkinson’s disease based on human induced pluripotent stem cells
US20230045590A1 (en) Genetically corrected cells for therapeutic use
US20250197803A1 (en) A method of differentiating an induced pluripotent stem cell into a retinal pigment epithelial cell, a retinal pigment epithelial cell and methods of using the retinal pigment epithelial cell
Belfiore et al. Combinatorial expression of glial transcription factors induces Schwann cell‐specific gene expression in mouse embryonic fibroblasts
Bonsi et al. Stem cells
Melguizo Sanchis Modelling severe paediatric aplastic anaemia using induced pluripotent stem cell technology
Alvarez Stem Cell Biology and Strategies for Therapeutic Development in Degenerative Diseases and Cancer
De Lazaro Del Rey In vivo cell reprogramming to pluripotency: generating induced pluripotent stem cells in situ for tissue regeneration
Henning Identification and characterisation of a novel, multi-potent, skeletal muscle-derived stem cell with broad developmental plasticity

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180209

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20180814

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20180816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180814

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20181012

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20181012

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190422

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190422

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20190918

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20190920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200428

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200925

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20200930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20201002

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210526

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20211026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220222

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220222

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220302

TRDD Decision of grant or rejection written
C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220308

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220322

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220406

R150 Certificate of patent or registration of utility model

Ref document number: 7055638

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees